España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Revance Therapeutics
RVNC
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$3.84
0.04
1.05%
At close: -
$3.98
0.14
3.54%
After Hours: 5:06 PM EDT
Get Report
Comment
Revance Therapeutics (RVNC) Forecast
News
Earnings
Revance Therapeutics (RVNC) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Revance Therapeutics (NASDAQ:RVNC) Stock
Revance Therapeutics Stock (NASDAQ: RVNC)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, November 12, 2024
Tyson Foods Posts Better-Than-Expected Earnings, Joins Shopify, Sea, Buckle And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Friday, November 08, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Needham Reiterates Hold on Revance Therapeuti...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Neutral on Rev...
Benzinga Newsdesk
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Revance Therapeutics shares are trading lower...
Benzinga Newsdesk
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, November 07, 2024
Revance Therapeutics Q3 EPS $(0.37) Beats $(0...
Benzinga Newsdesk
Monday, October 28, 2024
Needham Reiterates Hold on Revance Therapeuti...
Benzinga Newsdesk
PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Market-Moving News for October 28th
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Revance Therapeutics shares are trading highe...
Benzinga Newsdesk
Revance Therapeutics And Teoxane Entered Into...
Benzinga Newsdesk
Monday, September 23, 2024
Revance Therapeutics shares are trading lower...
Benzinga Newsdesk
Reported Earlier: Revance Therapeutics Denies...
Benzinga Newsdesk
Monday, September 16, 2024
Watching Revance Therapeutics; Shares Trading...
Benzinga Newsdesk
Friday, September 13, 2024
Barclays Downgrades Revance Therapeutics to E...
Benzinga Newsdesk
Tuesday, August 13, 2024
Needham Downgrades Revance Therapeutics to Ho...
Benzinga Newsdesk
Monday, August 12, 2024
Guggenheim Downgrades Revance Therapeutics to...
Benzinga Newsdesk
Gold Gains Over 1%; Starbucks Shares Move Higher
Avi Kapoor
William Blair Downgrades Revance Therapeutics...
Benzinga Newsdesk
Crude Oil Surges 2%; B. Riley Financial Shares Plunge
Avi Kapoor
Botox Innovator Revance Therapeutics Goes Private In Over $900M Deal
Vandana Singh
KE Holdings, KeyCorp, Revance Therapeutics, Starbucks And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Dow Dips 150 Points; Monday.com Posts Upbeat Earnings
Avi Kapoor
Revance Therapeutics shares are trading highe...
Benzinga Newsdesk
Revance Therapeutics Shares Resumed Trading A...
Benzinga Newsdesk
Trading Halt: Halt status updated at 8:25:00 ...
Benzinga Newsdesk
Crown Laboratories And Revance Therapeutics A...
Benzinga Newsdesk
Trading Halt: Halted at 7:55:00 a.m. ET - Tra...
Benzinga Newsdesk
Friday, August 09, 2024
Revance Therapeutics shares are trading highe...
Benzinga Newsdesk
Piper Sandler Maintains Overweight on Revance...
Benzinga Newsdesk
Stifel Maintains Buy on Revance Therapeutics,...
Benzinga Newsdesk
Needham Reiterates Buy on Revance Therapeutic...
Benzinga Newsdesk
Thursday, August 08, 2024
Revance Therapeutics Sees FY24 Net Product Re...
Benzinga Newsdesk
Revance Therapeutics Q2 2024 GAAP EPS $(0.36)...
Benzinga Newsdesk
Monday, May 13, 2024
HC Wainwright & Co. Maintains Buy on Revance ...
Benzinga Newsdesk
Goldman Sachs Maintains Neutral on Revance Th...
Benzinga Newsdesk
Friday, May 10, 2024
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Revance Therapeutics shares are trading lower...
Benzinga Newsdesk
These Analysts Lower Their Forecasts On Revance Therapeutics After Q1 Results
Avi Kapoor
Piper Sandler Reiterates Overweight on Revanc...
Benzinga Newsdesk
Mizuho Maintains Neutral on Revance Therapeut...
Benzinga Newsdesk
Needham Maintains Buy on Revance Therapeutics...
Benzinga Newsdesk
Thursday, May 09, 2024
Revance Continues To Expect 2024 Total Net Pr...
Benzinga Newsdesk
Revance Therapeutics Q1 2024 GAAP EPS $(0.54)...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch